| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.26 (Beat by $0.01) |
| EPS GAAP Actual | $0.26 (Beat by $0.01) |
| Revenue Actual | $0.197599B |
| Revenue Surprise | Beat by $197.599M |
| Announce Date | 03/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.24 |
| EPS GAAP Estimate | $0.24 |
| Revenue Estimate | $0.1474B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 1.8 | 40.21 | 1.76959 | 1.81868 | 0 |
| Dec 2025 | 0.99 | 73.1 | 0.86625 | 1.01531 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.04 | 0.04 | 0.197599B | 31.42% | 197.6M |
| FQ2 2025 (Jun 2025) | 0.27 | 0.27 | 0.185391B | 25.82% | 185.39M |
| FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 0.176697B | 28.5% | 176.7M |
| FQ4 2024 (Dec 2024) | 0.14 | 0.14 | 0.158566B | 3.06% | 158.57M |
| FQ3 2024 (Sep 2024) | 0.0599 | 0.0599 | 0.135513B | -10.24% | 135.51M |
| FQ2 2024 (Jun 2024) | 0.13 | 0.13 | 0.137522B | 6.07% | 137.52M |
| FQ1 2024 (Mar 2024) | 0.0433 | 0.0433 | 0.126332B | 10.9% | 126.33M |
| FQ4 2023 (Dec 2023) | 0.11 | 0.11 | 0.153711B | 24.27% | 153.71M |
FQ4 Announce Date
03/31/2026 (Pre-Market)
Consensus EPS Estimates
0.24
Consensus Revenue Estimates
0.1474B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.685 | -- | 0.65127 | 0.71752 | 1 |
| FQ3 2027 (Sep 2027) | 0.565 | -- | 0.53718 | 0.59182 | 1 |
| FQ2 2027 (Jun 2027) | 0.45 | -- | 0.42784 | 0.47136 | 1 |
| FQ1 2027 (Mar 2027) | 0.29 | -- | 0.27572 | 0.30377 | 1 |
| FQ4 2026 (Dec 2026) | 0.59667 | -- | 0.56729 | 0.62499 | 1 |
| FQ3 2026 (Sep 2026) | 0.385 | 89.61 | 0.36604 | 0.40328 | 1 |
| FQ2 2026 (Jun 2026) | 0.34333 | 21.36 | 0.32643 | 0.35963 | 1 |
| FQ1 2026 (Mar 2026) | 0.24 | -329.17 | 0.2356 | 0.2444 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26B | -- | 0.25B | 0.27B | 2 |
| FQ3 2027 (Sep 2027) | 0.25B | -- | 0.24B | 0.26B | 2 |
| FQ2 2027 (Jun 2027) | 0.23B | -- | 0.22B | 0.24B | 2 |
| FQ1 2027 (Mar 2027) | 0.21B | -- | 0.2B | 0.22B | 2 |
| FQ4 2026 (Dec 2026) | 0.25B | -- | 0.24B | 0.25B | 2 |
| FQ3 2026 (Sep 2026) | 0.23B | 14.15 | 0.22B | 0.24B | 2 |
| FQ2 2026 (Jun 2026) | 0.21B | 12.36 | 0.2B | 0.22B | 2 |
| FQ1 2026 (Mar 2026) | 0.15B | -19.88 | 0.15B | 0.15B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.04 | 0.04 | 100% | |
| FQ2 2025 (Jun 2025) | 0.27 | 0.27 | 100% | |
| FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 100% | |
| FQ4 2024 (Dec 2024) | 0.14 | 0.14 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0599 | 0.0599 | 100% | |
| FQ2 2024 (Jun 2024) | 0.13 | 0.13 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0433 | 0.0433 | 100% | |
| FQ4 2023 (Dec 2023) | 0.11 | 0.11 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.2B | $197.6M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.19B | $185.39M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.18B | $176.7M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.16B | $158.57M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.14B | $135.51M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.14B | $137.52M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.13B | $126.33M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.15B | $153.71M | 100% |